Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review

References

• Abali, H., Oyan, B. & Guler, N. (2005). Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer. Chemotherapy, 51, 280–285.
   PubMed Web of Science ®Google Scholar
• Ahern, T.P., Pedersen, L., Cronin-Fenton, D.P., Sørensen, H.T. & Lash, T.L. (2009). No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications. Cancer Epidemiology Biomarkers and Prevention, 18, 2562–2564.
   PubMed Web of Science ®Google Scholar
• Amodeo, L., Castelli, L., Leombruni, P., Cipriani, D., Biancofiore, A. & Torta, R. (2012). Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: A pilot study. Supportive Care in Cancer, 20, 375–384.
   PubMed Web of Science ®Google Scholar
• Ang, S.K., Shoemaker, L.K. & Davis, M.P. (2010). Nausea and vomiting in advanced cancer. American Journal of Hospice and Palliative Care, 27, 219–225.
   PubMed Web of Science ®Google Scholar
• Argov, M., Kashi, R., Peer, D. & Margalit, R. (2009). Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen. Cancer Letters, 274, 118–125.
   PubMed Web of Science ®Google Scholar
• Azoulay, L., Yin, H., Renoux, C. & Suissa, S. (2011). The use of atypical antipsychotics and the risk of breast cancer. Breast Cancer Research and Treatment, 129, 541–548.
   PubMed Web of Science ®Google Scholar
• Baldwin, K.J., Zivković, S.A. & Lieberman, F.S. (2012). Neurologic emergencies in patients who have cancer: diagnosis and management. Neurologic Clinics, 30, 101–128.
   PubMedGoogle Scholar
• Bendaly, E.A., Jordan, C.A., Staehler, S.S. & Rushing, D.A. (2007). Topiramate in the treatment of neuropathic pain in patients with cancer. Support Cancer Therapy, 4, 241–246.
   PubMedGoogle Scholar
• Bennett, M.I. (2011). Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: Systematic review. Palliative Medicine, 25, 553–539.
   PubMedGoogle Scholar
• Bennett, M.I., Laird, B., Van Litsenburg, C. & Nimour, M. (2013). Pregabalin for the management of neuropathic pain in adults with cancer: A systematic review of the literature. Pain Medicine,14, 1681–1688.
   PubMed Web of Science ®Google Scholar
• Binkhorst, L., Mathijssen, R.H., Van Herk-Sukel, M.P., Bannink, M., Jager, A., Wiemer, E.A. & van Gelder, T. (2013). Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen. Breast Cancer Research and Treatment, 39, 923–929.
   Google Scholar
• Bodén, R., Edman, G., Reutfors, J., Ostenson, C.G. & Osby, U. (2013). A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice. Neuropsychiatric Disease and Treatment, 9, 371–377.
   PubMed Web of Science ®Google Scholar
• Boettger, S. & Breitbart, W. (2005). Atypical antipsychotics in the management of delirium: A review of the empirical literature. Palliative and Supportive Care, 3, 227–237.
   PubMedGoogle Scholar
• Boettger, S., Friedlander, M., Breitbart, W. & Passik, S. (2011). Aripiprazole and haloperidol in the treatment of delirium. Australian and New Zealand Journal of Psychiatry, 45, 477–482.
   PubMed Web of Science ®Google Scholar
• Bordeleau, L., Pritchard, K., Goodwin, P. & Loprinzi, C. (2007). Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. Clinical Therapeutics Journal, 29, 230–341.
   PubMed Web of Science ®Google Scholar
• Bordeleau, L., Pritchard, K.I., Loprinzi, C.L., Ennis, M., Jugovic, O., Warr, D., … Goodwin, P.J. (2010). Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. Journal of Clinical Oncology, 1028, 5147–5152.
   Google Scholar
• Breitbart, W. & Alici, Y. (2010). Psychostimulants for cancer- related fatigue. Journal of the National Comprehensive Cancer Network, 8, 933–942.
   PubMed Web of Science ®Google Scholar
• Breitbart, W. & Alici, Y. (2012). Evidence-based treatment of delirium in patients with cancer. Journal of Clinical Oncology, 30, 1206–1214.
   PubMedGoogle Scholar
• Breitbart, W. & Alici-Evcimen, Y. (2007). Update on psychotropic medications for cancer-related fatigue. Journal of the National Comprehensive Cancer Network, 5, 1081–1091.
   PubMedGoogle Scholar
• Caley, C.F. (2011). Interpreting and applying CYP450 genomic test results to psychotropic medications. Journal of Pharmacy Practice, 24, 439–446.
   PubMedGoogle Scholar
• Candy, B., Jackson, K.C., Jones, L., Leurent, B., Tookman, A. & King, M. (2012a). Drug therapy for delirium in terminally ill adult patients. Cochrane Database of Systematic Reviews, 11, CD004770.
   PubMedGoogle Scholar
• Candy, B., Jackson, K.C., Jones, L., Tookman, A. & King, M. 2012b). Drug therapy for symptoms associated with anxiety in adult palliative care patients. Cochrane Database of Systematic Reviews, 10, CD004596.
   PubMedGoogle Scholar
• Candy, M., Jones, L., Williams, R., Tookman, A. & King, M. (2008). Psychostimulants for depression. Cochrane Database of Systematic Reviews, 2, CD006722.
   Google Scholar
• Cankurtaran, E.S., Ozalp, E., Soygur, H., Akbiyik, D.I., Turhan, L. & Alkis, N. (2008). Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: Superiority over imipramine. Supportive Care in Cancer, 16, 1291–1298.
   PubMed Web of Science ®Google Scholar
• Capuron, L., Neurauter, G., Musselman, D.L., Lawson, D.H., Nemeroff, C.B., Fuchs, D. & Miller, A.H. (2003). Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biological Psychiatry, 54, 906–914.
   Google Scholar
• Caraceni, A. & Grassi, L. (2011). Delirium: Acute Confusional States in Palliative Medicine (2nd ed.). Oxford: Oxford University Press.
   Google Scholar
• Caraceni, A. & Simonetti, F. (2009). Palliating delirium in patients with cancer. Lancet Oncology, 10, 164–172.
   PubMed Web of Science ®Google Scholar
• Caraci, F., Crupi, R., Drago, F. & Spina, E. (2011). Metabolic drug interactions between antidepressants and anticancer drugs: Focus on selective serotonin reuptake inhibitors and hypericum extract. Current Drug Metabolism, 12, 570–577.
   PubMed Web of Science ®Google Scholar
• Caruso, R., Grassi, L., Nanni, M.G. & Riba, M. (2013). Psychopharmacology in psycho-oncology. Current Psychiatry Reports, 15(9), 393.
   PubMedGoogle Scholar
• Chan, A., Ng, T.R. & Yap, K.Y. (2012). Clinically-relevant anticancer-antidepressant drug interactions. Expert Opinion on Drug Metabolism and Toxicology, 8, 173–199.
   PubMed Web of Science ®Google Scholar
• Chandwani, K.D., Ryan, J.L., Peppone, L.J., Janelsins, M.M., Sprod, L.K., Devine, K., … Mustian, K.M. (2012). Cancer-related stress and complementary and alternative medicine: A review. Evidence Based Complementary and Alternative Medicine, 2012, 979213.
   PubMedGoogle Scholar
• Chaturvedi, S.K., Maguire, P. & Hopwood, P. (1994). Antidepressant medications in cancer patients. Psycho-Oncology, 3, 57–60.
   Google Scholar
• Clevenger, C.V., Zheng, J., Jablonski, E.M., Galbaugh, T.M. & Fang, F. (2008). From bench to bedside: Future potential for the translation of prolactin inhibitors as breast cancer therapeutics. Journal of Mammary Gland Biology and Neoplasia, 13, 147–156.
   PubMedGoogle Scholar
• Costa, D., Mogos, I. & Toma, T. (1985). Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatrica Scandinavica Supplementum, 320, 85–92.
   PubMedGoogle Scholar
• Costantini, C., Ale-Ali, A. & Helsten, T. (2011). Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer. Journal of Palliative Medicine, 14, 563–566.
   PubMed Web of Science ®Google Scholar
• Cowan, J.D. & Palmer, T.W. (2002). Practical guide to palliative sedation. Current Oncology Reports, 4, 242–249.
   PubMedGoogle Scholar
• De Bock, G.H., Musters, R.F., Bos, H.J., Schröder, C.P., Mourits, M.J. & de Jong-van den Berg, L.T. (2012). Psychotropic medication during endocrine treatment for breast cancer. Supportive Care in Cancer, 20, 1533–1540.
   PubMed Web of Science ®Google Scholar
• Derogatis, L.R., Feldstein, M., Morrow, G., Schmale, A., Schmitt, M., Gates, C., … Adler, L.M. (1979). A survey of psychotropic drug prescriptions in an oncology population. Cancer, 44, 1919–1929.
   PubMed Web of Science ®Google Scholar
• Desmarais, J.E. & Looper, K.J. (2009). Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. Journal of Clinical Psychiatry, 70, 1688–1697.
   PubMed Web of Science ®Google Scholar
• Desplenter, F., Bond, C., Watson, M., Burton, C., Murchie, P., Lee, A.J., … Laekeman, G. (2012). Incidence and drug treatment of emotional distress after cancer diagnosis: A matched primary care case-control study. British Journal of Cancer, 107, 1644–1651.
   PubMedGoogle Scholar
• Deyell, R.J., Lorenzi, M., Ma, S., Rassekh, S.R., Collet, J.P., Spinelli, J.J., McBride, M.L. (2013). Antidepressant use among survivors of childhood, adolescent and young adult cancer: A report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. Pediatric Blood and Cancer, 60, 816–822.
   PubMedGoogle Scholar
• Dezentjé, V.O., van Blijderveen, N.J., Gelderblom, H., Putter, H., van Herk-Sukel, M.P., Casparie, M.K., … Guchelaar, H.J. (2010). Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. Journal of Clinical Oncology, 28, 2423–2429.
   PubMed Web of Science ®Google Scholar
• Di Paolo, A., Bocci, G., Polillo, M., Del Re, M., Di Desidero, T., Lastella, M. & Danesi, R. (2012). Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity. Current Drug Metabolism, 12, 932–943.
   Google Scholar
• Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R. & Walley, T. (2004). Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: A systematic review and meta-analysis. Human Psychopharmacology, 19, 305–322.
   PubMed Web of Science ®Google Scholar
• Dusetzina, S.B., Alexander, G.C., Freedman, R.A., Huskamp, H.A. & Keating, N.L. (2013). Trends in co- prescribing of antidepressants and tamoxifen among women with breast cancer, 2004–2010. Breast Cancer Research and Treatment, 137, 285–296.
   PubMed Web of Science ®Google Scholar
• ElBeltagy, M., Mustafa, S., Umka, J., Lyons, L., Salman, A., Chur-yoe, G.T., … Wigmore, P.M. (2010). Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil. Behavioural Brain Research, 208, 112–117.
   PubMedGoogle Scholar
• Ell, K., Quon, B., Quinn, D.I., Dwight-Johnson, M., Wells, A., Lee, P.J. & Xie, B. (2007). Improving treatment of depression among low-income patients with cancer: The design of the ADAPt-C study. General Hospital Psychiatry, 29, 223–231.
   PubMedGoogle Scholar
• Elsayem, A., Bush, S.H., Munsell, M.F., Curry, E., III, Calderon, B.B., Paraskevopoulos, T., … Bruera, E. (2010). Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: A preliminary study. Journal of Pain and Symptom Management, 40, 774–782.
   PubMedGoogle Scholar
• Fallon, M.T. (2013). Neuropathic pain in cancer. British Journal of Anaesthesia, 111, 105–111.
   PubMed Web of Science ®Google Scholar
• Farriols, C., Ferrández, O., Planas, J. Ortiz, P., Mojal, S. & Ruiz, A.I. (2012). Changes in the prescription of psychotropic drugs in the palliative care of advanced cancer patients over a seven-year period. Journal of Pain and Symptom Management, 43, 945–952.
   PubMed Web of Science ®Google Scholar
• Fisher, W.I., Johnson, A.K., Elkins, G.R., Otte, J.L., Burns, D.S., Yu, M. & Carpenter, J.S. (2013). Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA: A Cancer Journal for Clinicians, 63, 167–192.
   PubMed Web of Science ®Google Scholar
• Gehring, K., Roukema, J.A. & Sitskoorn, M.M. (2012). Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy, 12, 255–269.
   PubMed Web of Science ®Google Scholar
• Gothelf, D., Rubinstein, M., Shemesh, E., Miller, O., Farbstein, I., Klein, A., ... Yaniv, I. (2005). Pilot study: Fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 1258–1262.
   PubMed Web of Science ®Google Scholar
• Grassi, L., Biancosino, B., Marmai, L., Righi, R. (2004). Effect of reboxetine on major depressive disorder in breast cancer patients: An open-label study. Journal of Clinical Psychiatry, 65, 515–520.
   PubMed Web of Science ®Google Scholar
• Grassi, L., Caruso, R. & Nanni, M.G. (2013). Somatization and somatic symptom presentation in cancer: A neglected area. International Review of Psychiatry, 25, 41–51.
   PubMed Web of Science ®Google Scholar
• Grassi, L., Nanni, M.G., Uchitomi, Y., Riba, M. (2011). Pharmacotherapy of depression in people with cancer. In D.W. Kissane, M. Maj, & N. Sartorius (Eds), Depression and Cancer (pp. 151–176). Chichester: Wiley.
   Google Scholar
• Grassi, L., & Riba, M. (2012). Introducing Multicultural Psycho-oncology. In L. Grassi & M. Riba (Eds), Clinical Psycho- Oncology: An International Perspective (pp. 3–10). Chichester: Wiley.
   Google Scholar
• Grassi, L. & Riba, M. (2014). Psychopharmacology in Oncology and Palliative Care. A Practical Manual. Heidelberg: Springer.
   Google Scholar
• Grover, S., Kumar, V. & Chakrabarti, S. (2011). Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. Journal of Psychosomatic Research, 71, 277–281.
   PubMed Web of Science ®Google Scholar
• Hart, S.L., Hoyt, M.A., Diefenbach, M., Anderson, D.R., Kilbourn, K.M., Craft, L.L., ... Stanton, A.L. (2012). Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. Journal of the National Cancer Institute, 104, 990–1004.
   PubMed Web of Science ®Google Scholar
• Hatta, K., Kishi, Y., Wada, K., Odawara, T., Takeuchi, T., Shiganami, T., … Nakamura, H. (2013). Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: A prospective observational study. International Journal of Geriatric Psychiatry, doi: 10.1002/gps.3999.
   Google Scholar
• Hawkins, S.B., Bucklin, M. & Muzyk, A.J. (2013). Quetiapine for the treatment of delirium. Journal of Hospice Medicine, 8, 215–220.
   PubMedGoogle Scholar
• Henry, N.L., Stearns, V., Flockhart, D.A., Hayes, D.F. & Riba, M. (2008). Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. American Journal of Psychiatry, 165, 1251–1255.
   PubMed Web of Science ®Google Scholar
• Hesse, L.M., von Moltke, L.L. & Greenblatt, D.J. (2003). Clinically important drug interactions with zopiclone, zolpidem and zaleplon. CNS Drugs, 17, 513–532.
   PubMed Web of Science ®Google Scholar
• Hirst, A. & Sloan, R. (2002). Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database of Systematic Reviews, 4, CD003346.
   Google Scholar
• Holland, J.C., Romano, S.J., Heiligenstein, J.H., Tepner, R.G. & Wilson, M.G. (1998). A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncology, 7, 291–300.
   PubMed Web of Science ®Google Scholar
• Homsi, J., Walsh, D. & Nelson, K.A. (2000). Psychostimulants in supportive care. Supportive Care in Cancer, 8, 385–397.
   PubMed Web of Science ®Google Scholar
• Hui, D., Reddy, A., Palla, S. & Bruera, E. (2011). Neuroleptic prescription pattern for delirium in patients with advanced cancer. Journal of Palliative Care, 27, 141–147.
   PubMed Web of Science ®Google Scholar
• Jackson, K.C. & Lipman, A.G. (2004). Drug therapy for anxiety in palliative care. Cochrane Database of Systematic Reviews, 1, CD004596.
   Google Scholar
• Jaeger, H., Morrow, G.R., Carpenter, P.J. & Brescia, F. (1985). A survey of psychotropic drug utilization by patients with advanced neoplastic disease. General Hospital Psychiatry, 7, 353–360.
   PubMed Web of Science ®Google Scholar
• Joffe, H., Partridge, A., Giobbie-Hurder, A., Li, X., Habin, K., Goss, P., Winer, E. & Garber, J. (2010). Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: A randomized, double-blind, placebo-controlled trial. Menopause, 17, 908–916.
   PubMedGoogle Scholar
• Johannessen Landmark, C. & Patsalos, P.N. (2010). Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Review of Neurotherapeutics, 10, 119–140.
   PubMed Web of Science ®Google Scholar
• Kannen, V., Hintzsche, H., Zanette, D.L., Silva, W.A. Jr, Garcia, S.B., Waaga-Gasser, A.M. & Stopper, H. (2012). Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model. PLoS One, 7(11), e50043.
   Google Scholar
• Kargiotis, O., Markoula, S. & Kyritsis, A.P. (2011). Epilepsy in the cancer patient. Cancer Chemotherapy Pharmacology, 67, 489–501.
   PubMedGoogle Scholar
• Kast, R.E. & Foley, K.F. (2007). Cancer chemotherapy and cachexia: Mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. European Journal of Cancer Care (England), 16, 351–354.
   PubMed Web of Science ®Google Scholar
• Kehl, K.A. (2004). Treatment of terminal restlessness: A review of the evidence. Journal of Pain and Palliative Care Pharmacotherapy, 18, 5–30.
   PubMedGoogle Scholar
• Kelly, C.M., Juurlink, D.N., Gomes, T., Duong-Hua, M., Pritchard, K.I., Austin, P.C. & Paszat, L.F. (2010). Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: A population based cohort study. British Medical Journal, 340, c693.
   PubMed Web of Science ®Google Scholar
• Kishi, Y., Kato, M., Okuyama, T. & Thurber, S. (2012). Treatment of delirium with risperidone in cancer patients. Psychiatry and Clinical Neurosciences, 66, 411–417.
   PubMedGoogle Scholar
• Kligman, L. & Younus, J. (2010). Management of hot flashes in women with breast cancer. Current Oncology, 17, 81–86.
   PubMed Web of Science ®Google Scholar
• Kripke, D.F., Langer, R.D. & Kline, L.E. (2012). Hypnotics’ association with mortality or cancer: A matched cohort study. British Medical Journal Open, 2, e000850.
   PubMed Web of Science ®Google Scholar
• Kris, M.G., Gralla, R.J., Clark, R.A., Tyson, L.B. & Groshen, S. (1987). Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial. Cancer, 60, 2816–2822.
   Google Scholar
• Laoutidis, Z.G. & Mathiak, K. (2013). Antidepressants in the treatment of depression/depressive symptoms in cancer patients: A systematic review and meta-analysis. BMC Psychiatry, 13, 140.
   PubMed Web of Science ®Google Scholar
• Lash, T.L., Cronin-Fenton, D., Ahern, T.P., Rosenberg, C.L., Lunetta, K.L., Silliman, R.A., … Hamilton-Dutoit, S. (2011). CYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark. Journal of the National Cancer Institute, 103, 489–500.
   PubMed Web of Science ®Google Scholar
• Lavigne, J.E., Heckler, C., Mathews, J.L., Palesh, O., Kirshner, J.J., Lord, R., … Mustian, K. (2012). A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors. Breast Cancer Research and Treatment, 136, 479–486.
   PubMed Web of Science ®Google Scholar
• Lawlor, P.G. & Bruera, E.D. (2002). Delirium in patients with advanced cancer. Hematology Oncology Clinics of North America, 16, 701–714.
   PubMedGoogle Scholar
• LeGrand, S.B. (2012). Delirium in palliative medicine: A review. Journal of Pain and Symptom Management, 44, 583–594.
   PubMed Web of Science ®Google Scholar
• Leonard, M., Agar, M., Mason, C. & Lawlor, P. (2008). Delirium issues in palliative care settings. Journal of Psychosomatic Research, 65, 289–298
   PubMed Web of Science ®Google Scholar
• Lertxundi, U., Hernandez, R., Medrano, J., Domingo-Echaburu, S., García, M. & Aguirre, C. (2013). Antipsychotics and seizures: Higher risk with atypicals?Seizure, 22, 141–143.
   PubMed Web of Science ®Google Scholar
• L’Espérance, S., Frenette, S., Dionne, A. , Dionne, J.Y. & Comité de l’Evolution des Pratiques en Oncologie (CEPO) (2013). Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations. Supportive Care in Cancer, 21, 1461–1474.
   PubMed Web of Science ®Google Scholar
• Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Orey, D., Richter, F., … Davis, J.M. (2013). Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis. Lancet, 382(9896), 951–962.
   PubMedGoogle Scholar
• Leucht, S., Corves, C., Arbter, D., Engel, R.R., Li, C. & Davis, J.M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet, 373(9671), 31–41.
   PubMedGoogle Scholar
• Leucht, S., Wahlbeck, K., Hamann, J. & Kissling, W. (2003). New generation antipsychotics versus low-potency conventional antipsychotics: A systematic review and meta-analysis. Lancet, 361(9369), 1581–1589.
   PubMedGoogle Scholar
• Li, M., Fitzgerald, P. & Rodin, G. (2012). Evidence-based treatment of depression in patients with cancer. Journal of Clinical Oncology, 30, 1187–1196.
   PubMed Web of Science ®Google Scholar
• Licup, N. (2010). Olanzapine for nausea and vomiting. American Journal of Hospice and Palliative Care, 27, 432–434.
   PubMedGoogle Scholar
• Lindqvist, O., Lundquist, G., Dickman, A., Bükki, J., Lunder, U., Hagelin, C.L., … Fürst, C.J. (2013). OPCARE9.Four essential drugs needed for quality care of the dying: A Delphi-study based international expert consensus opinion. Journal of Palliative Medicine, 16, 38–43.
   PubMed Web of Science ®Google Scholar
• Lloyd-Williams, M. (2003). Depression – The hidden symptom in advanced cancer. Journal of the Royal Society of Medicine, 96, 577–581.
   PubMed Web of Science ®Google Scholar
• Lorenz, R.A., Jackson, C.W. & Saitz, M. (2010). Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder. Pharmacotherapy, 30, 942–951.
   PubMedGoogle Scholar
• Lyons, L., ElBeltagy, M., Umka, J., Markwick, R., Startin, C., Bennett, G. & Wigmore, P. (2011). Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. Psychopharmacology (Berlin), 215, 105–115.
   PubMed Web of Science ®Google Scholar
• Maltoni, M., Scarpi, E., Rosati, M., Derni, S., Fabbri, L., Martini, F., … Nanni, O. (2012). Palliative sedation in end-of-life care and survival: A systematic review. Journal of Clinical Oncology, 30, 1378–1383.
   PubMed Web of Science ®Google Scholar
• Maneeton, B., Maneeton, N., Srisurapanont, M. & Chittawatanarat, K. (2013). Quetiapine versus haloperidol in the treatment of delirium: A double-blind, randomized, controlled trial. Drug Design, Development and Therapy, 7, 657–667.
   PubMed Web of Science ®Google Scholar
• Mantovani, G. & Madeddu, C. (2010). Cancer cachexia: Medical management. Supportive Care in Cancer, 18, 1–9.
   PubMed Web of Science ®Google Scholar
• Masand, P.S. & Tesar, G.E. (1996). Use of stimulants in the medically ill. Psychiatric Clinics of North America, 19, 515–547.
   PubMed Web of Science ®Google Scholar
• Maschio, M. (2012). Brain tumor-related epilepsy. Current Neuropharmacology, 10, 124–133.
   PubMed Web of Science ®Google Scholar
• Maschio, M., Dinapoli, L., Mingoia, M., Sperati, F., Pace, A., Pompili, A., …. Muti, P. (2011). Lacosamide as add-on in brain tumor-related epilepsy: Preliminary report on efficacy and tolerability. Journal of Neurology, 258, 2100–2104.
   PubMed Web of Science ®Google Scholar
• Mazzocato, C., Stiefel, F., Buclin, T. & Berney, A. (2000). Psychopharmacology in supportive care of cancer: A review for the clinician: II. Neuroleptics. Supportive Care in Cancer, 8, 89–97.
   PubMed Web of Science ®Google Scholar
• Miguel, C. & Albuquerque, E. (2011). Drug interaction in psycho-oncology: Antidepressants and antineoplastics. Pharmacology, 88, 333–339.
   PubMedGoogle Scholar
• Minton, O., Richardson, A., Sharpe, M., Hotopf, M. & Stone, P. (2008). A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. Journal of the National Cancer Institute, 100, 1155–1166.
   PubMed Web of Science ®Google Scholar
• Minton, O., Richardson, A., Sharpe, M., Hotopf, M. & Stone, P.C. (2011). Psychostimulants for the management of cancer-related fatigue: A systematic review and meta-analysis. Journal of Pain and Symptom Management, 41, 761–767.
   PubMed Web of Science ®Google Scholar
• Miovic, M. & Block, S. (2007). Psychiatric disorders in advanced cancer. Cancer, 110, 1665–1676.
   PubMed Web of Science ®Google Scholar
• Mishra, S., Bhatnagar, S., Goyal, G.N., Rana, S.P. & Upadhya, S.P. (2012). A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. American Journal of Hospice and Palliative Care, 29, 177–182.
   PubMed Web of Science ®Google Scholar
• Mitchell, A.J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C. & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncology, 12, 160–174.
   PubMed Web of Science ®Google Scholar
• Montgomery, S.A., Baldwin, D.S. & Riley, A. (2002). Antidepressant medications: A review of the evidence for drug-induced sexual dysfunction. Journal of Affective Disorders, 69, 119–140.
   PubMed Web of Science ®Google Scholar
• Morrow, P.K., Mattair, D.N. & Hortobagyi, G.N. (2011). Hot flashes: A review of pathophysiology and treatment modalities. Oncologist, 16, 1658–1664.
   PubMed Web of Science ®Google Scholar
• Mula, M. (2008). Anticonvulsants – Antidepressants pharmacokinetic drug interactions: The role of the CYP450 system in psychopharmacology. Current Drug Metabolism, 9, 730–737.
   PubMed Web of Science ®Google Scholar
• Murray, M. (2006). Role of CYP pharmacogenetics and drug–drug interactions in the efficacy and safety of atypical and other antipsychotic agents. Journal of Pharmacy and Pharmacology, 58, 871–885.
   PubMed Web of Science ®Google Scholar
• Musselman, D.L., Lawson, D.H., Gumnick, J.F., Manatunga, A.K., Penna, S., Goodkin, R.S., … Miller, A.H. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine, 344, 961–966.
   PubMed Web of Science ®Google Scholar
• Musselman, D.L., Somerset, W.I., Guo, Y., Manatunga, A.K., Porter, M., Penna, S., … Nemeroff, C.B. (2006). A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. Journal of Clinical Psychiatry, 67, 288–296.
   PubMedGoogle Scholar
• Newcomer, J.W. (2005). Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs, 19, S1–93.
   PubMed Web of Science ®Google Scholar
• Newcomer, J.W. (2007). Antipsychotic medications: Metabolic and cardiovascular risk. Journal of Clinical Psychiatry,68(Suppl.4), S8–13.
   PubMed Web of Science ®Google Scholar
• Ng, C.G., Boks, M.P., Smeets, H.M., Zainal, N.Z. & de Wit, N.J. (2013). Prescription patterns for psychotropic drugs in cancer patients: A large population study in the Netherlands. Psycho-Oncology, 22, 762–767.
   PubMedGoogle Scholar
• Ng, C.G., Boks, M.P., Zainal, N.Z. & de Wit, N.J. (2011). The prevalence and pharmacotherapy of depression in cancer patients. Journal of Affective Disorders, 131, 1–7.
   PubMed Web of Science ®Google Scholar
• Nooijen, P.M., Carvalho, F. & Flanagan, R.J. (2011). Haematological toxicity of clozapine and some other drugs used in psychiatry. Human Psychopharmacology, 26, 112–119.
   PubMed Web of Science ®Google Scholar
• Okamura, M., Akizuki, N., Nakano, T., Shimizu, K., Ito, T., Akechi, T. & Uchitomi, Y. (2008). Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. Psycho-Oncology, 17, 154–160.
   PubMedGoogle Scholar
• Orr, K. & Taylor, D. (2007). Psychostimulants in the treatment of depression: A review of the evidence. CNS Drugs, 21, 239–257.
   PubMed Web of Science ®Google Scholar
• Ouwens, M., Hulscher, M., Hermens, R., Faber, M., Marres, H., Wollersheim, H. & Grol, R. (2009). Implementation of integrated care for patients with cancer: A systematic review of interventions and effects. International Journal for Quality in Health Care, 21, 137–144.
   PubMed Web of Science ®Google Scholar
• Pachman, D.R., Barton, D.L., Watson, J.C. & Loprinzi, C.L. (2011). Chemotherapy-induced peripheral neuropathy: Prevention and treatment. Clinical Pharmacology and Therapeutics, 90, 377–387.
   PubMed Web of Science ®Google Scholar
• Pae, C.U., Kim, Y.J., Won, W.Y., Kim, H.J., Lee, S., Lee, C.U., … Serretti, A. (2004). Paroxetine in the treatment of depressed patients with haematological malignancy: An open-label study. Human Psychopharmacology, 19, 25–29.
   PubMedGoogle Scholar
• Palesh, O.G., Mustian, K.M., Peppone, L.J., Janelsins, M., Sprod, L.K. & Kesler, S., (2012). Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: A trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Medicine, 13, 1184–1190.
   PubMed Web of Science ®Google Scholar
• Pandya, K.J., Morrow, G.R., Roscoe, J.A., Zhao, H., Hickok, J.T., Pajon, E., … Flynn, P.J. (2005). Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial. Lancet, 366(9488), 818–824.
   PubMedGoogle Scholar
• Patkar, A.A. & Pae, C.U. (2013). Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder. CNS Drugs, 27, S29–37.
   PubMedGoogle Scholar
• Patsalos, P.N. (2013). Drug interactions with the newer antiepileptic drugs (AEDs) – Part 1: Pharmacokinetic and pharmacodynamic interactions between AEDs. Clinical Pharmacokinetics, doi:10.1007/s40262-013-0087-0
   Google Scholar
• Pezzella, G., Moslinger-Gehmayr, R. & Contu, A. (2001). Treatment of depression in patients with breast cancer: A comparison between paroxetine and amitriptyline. Breast Cancer Research and Treatment, 70, 1–10.
   PubMedGoogle Scholar
• Portela, M.A., Rubiales, A.S. & Centeno, C. (2011). The use of psychostimulants in cancer patients. Current Opinion in Supportive and Palliative Care, 5, 164–168.
   PubMedGoogle Scholar
• Pruitt, A.A. (2011). Medical management of patients with brain tumors. Current Treatment Options in Neurology, 13, 413–426.
   PubMedGoogle Scholar
• Rayner, L., Price, A., Evans, A., Valsraj, K., Hotopf, M. & Higginson, I.J. (2011a). Antidepressants for the treatment of depression in palliative care: Systematic review and meta-analysis. Palliative Medicine, 25, 36–51.
   PubMedGoogle Scholar
• Rayner, L., Price, A., Hotopf, M. & Higginson, I.J. (2011b). The development of evidence-based European guidelines on the management of depression in palliative cancer care. European Journal of Cancer, 47, 702–712.
   PubMed Web of Science ®Google Scholar
• Razavi, D., Allilaire, J.F., Smith, M., Salimpour, A., Verra, M., Desclaux, B., … Blin, P. (1996). The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatrica Scandinavica, 94, 205–210.
   PubMed Web of Science ®Google Scholar
• Reddy, K.K., Lefkove, B., Chen, L.B., Govindarajan, B., Carracedo, A., Velasco, G., … Arbiser, J.L. (2008). The antidepressant sertraline down regulates Akt and has activity against melanoma cells. Pigment Cell and Melanoma Research, 21, 451–456.
   PubMedGoogle Scholar
• Riechelmann, R.P., Burman, D., Tannock, I.F., Rodin, G. & Zimmermann, C. (2010). Phase II trial of mirtazapine for cancer-related cachexia and anorexia. American Journal of Hospice and Palliative Care, 27, 106–110.
   PubMedGoogle Scholar
• Ripamonti, C., Santini, D., Maranzano, E., Berti, M., & Roila, F. on behalf of the ESMO Guidelines Working Group. (2012). Management of cancer pain: ESMO Clinical Practice Guidelines. Annals of Oncology, 23(Suppl.7), 139–154.
   Google Scholar
• Rodin, G., Lloyd, N., Katz, M., Green, E., Mackay, J.A., Wong, R.K. & Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care (2007). The treatment of depression in cancer patients: A systematic review. Supportive Care in Cancer, 15, 123–136.
   PubMed Web of Science ®Google Scholar
• Roscoe, J.A., Morrow, G.R., Aapro, M.S., Molassiotis, A., & Olver, I. (2011). Anticipatory nausea and vomiting. Supportive Care in Cancer, 19, 1533–1538.
   PubMed Web of Science ®Google Scholar
• Samer, C.F., Lorenzini, K.I., Rollason, V., Daali, Y. & Desmeules, J.A. (2013). Applications of CYP450 testing in the clinical setting. Molecular Diagnosis and Therapy, 17, 165–184.
   PubMed Web of Science ®Google Scholar
• Saria, M.G., Corle, C., Hu, J., Rudnick, J.D., Phuphanich, S., Mrugala, M.M., … Kesari, S. (2013). Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: Clinical article. Journal of Neurosurgery, 118, 1183–1187.
   PubMed Web of Science ®Google Scholar
• Savard, J. & Morin, C.M. (2001). Insomnia in the context of cancer: A review of a neglected problem. Journal of Clinical Oncology, 19, 895–908.
   PubMed Web of Science ®Google Scholar
• Singer, S., Das-Munshi, J. & Brähler, E. (2010). Prevalence of mental health conditions in cancer patients in acute care – A meta-analysis. Annals of Oncology, 21, 925–930.
   PubMed Web of Science ®Google Scholar
• Smith, E.M., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E.D., Ahles, T., … Shapiro, C.L. (2013). Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial.Journal of the American Medical Association, 309, 1359–1367.
   PubMed Web of Science ®Google Scholar
• Spina, E., Santoro, V. & D’Arrigo, C. (2008). Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clinical Therapeutics, 30, 1206–1227.
   PubMed Web of Science ®Google Scholar
• Spina, E., Trifirò, G. & Caraci, F. (2012). Clinically significant drug interactions with newer antidepressants. CNS Drugs, 26, 39–67.
   PubMed Web of Science ®Google Scholar
• Stahl, S.M. (2009). Multifunctional drugs: A novel concept for psychopharmacology. CNS Spectrum, 14, 71–73.
   PubMed Web of Science ®Google Scholar
• Stahl, S.M. (2013). Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications (4th ed.). New York: Cambridge University Press.
   Google Scholar
• Sternbach, H. (2003). Are antidepressants carcinogenic? A review of preclinical and clinical studies. Journal of Clinical Psychiatry, 64, 1153–1162.
   PubMed Web of Science ®Google Scholar
• Stiefel, F.C., Kornblith, A.B. & Holland, J.C. (1990). Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer, 65, 1048–53.
   PubMed Web of Science ®Google Scholar
• Stiefel, F., Berney, A. & Mazzocato, C. (1999). Psychopharmacology in supportive care in cancer: A review for the clinician. I. Benzodiazepines. Supportive Care in Cancer, 7, 379–385.
   PubMedGoogle Scholar
• Stockler, M.R., O’Connell, R., Nowak, A.K., Goldstein, D., Turner, J., Wilcken, N.R., … Simes, R.J. (2007). Zoloft's Effects on Symptoms and Survival Time Trial Group. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: A placebo-controlled double-blind randomised trial.Lancet Oncology, 8, 603–612.
   PubMedGoogle Scholar
• Strong, V., Waters, R., Hibberd, C., Murray, G., Wall, L., Walker, J., … Sharpe, M. (2008). Management of depression for people with cancer (SMaRT oncology 1): A randomised trial. Lancet, 372, 40–48
   PubMed Web of Science ®Google Scholar
• Suttajit, S., Srisurapanont, M., Xia, J., Suttajit, S., Maneeton, B. & Maneeton, N. (2013). Quetiapine versus typical antipsychotic medications for schizophrenia. Cochrane Database of Systematic Reviews, 5, CD007815.
   Google Scholar
• Tanimukai, H., Murai, T., Okazaki, N., Matsuda, Y., Okamoto, Y., Kabeshita, Y., … Tsuneto, S. (2013). An observational study of insomnia and nightmare treated with trazodone in patients with advanced cancer. American Journal of Hospice and Palliative Care, 30, 359–362.
   PubMedGoogle Scholar
• Testa, A., Giannuzzi, R., Sollazzo, F., Petrongolo, L., Bernardini, L. & Dain, S. (2013). Psychiatric emergencies (Part II): Psychiatric disorders coexisting with organic diseases. European Review for Medical and Pharmacological Sciences, 17, S65–85.
   PubMed Web of Science ®Google Scholar
• Thekdi, S.M., Irarrazaval, M.E. & Dunn, L. (2012). Psychopharmacological Interventions. In Grassi, L. & Riba, M. (Eds.) Clinical Psycho-Oncology: An International Perspective (pp. 109–126). Chichester: Wiley.
   Google Scholar
• Theobald, D.E., Kirsh, K.L., Holtsclaw, E., Donaghy, K. & Passik, S.D. (2002). An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. Journal of Pain and Symptom Management, 23, 442–447.
   PubMed Web of Science ®Google Scholar
• Thomson, K. & Henry, B. (2012). Oncology clinical challenges: Caring for patients with preexisting psychiatric illness. Clinical Journal of Oncology Nursing, 16, 471–480.
   PubMedGoogle Scholar
• Torta, R., Berra, C., Binaschi, L. & Borio, R. (2007). Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies. Supportive Care in Cancer, 15, 539–546.
   PubMedGoogle Scholar
• Torta, R., Leombruni, P., Borio, R. & Castelli, L. (2011). Duloxetine for the treatment of mood disorder in cancer patients: A 12-week case-control clinical trial. Human Psychopharmacology, 26, 291–299.
   PubMed Web of Science ®Google Scholar
• Torta, R., Siri, I. & Caldera, P. (2008). Sertraline effectiveness and safety in depressed oncological patients. Supportive Care in Cancer, 16, 83–91.
   PubMedGoogle Scholar
• Tsavaris, N., Kosmas, C., Vadiaka, M., Sougioultzis, S., Kontos, A., Agelopoulou, A., … Koufos, C. (2001). Comparative study of tropisetron with the addition of dexamethasone or alprazolam in breast cancer patients receiving adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil). Journal of Chemotherapy, 13, 641–647.
   PubMed Web of Science ®Google Scholar
• Vaidya, R., Sood, R., Karlin, N. & Jatoi, A. (2011). Benzodiazepine use in breast cancer survivors: Findings from a consecutive series of 1,000 patients. Oncology, 81, 9–11.
   PubMed Web of Science ®Google Scholar
• Van Heeringen, K. & Zivkov, M. (1996). Pharmacological treatment of depression in cancer patients. A placebo- controlled study of mianserin. British Journal of Psychiatry, 169, 440–443.
   PubMedGoogle Scholar
• Wang, P.W. & Ketter, T.A. (2002). Pharmacokinetics of mood stabilizers and new anticonvulsants. Psychopharmacology Bulletin, 36, 44–66.
   PubMedGoogle Scholar
• Wasteson, E., Brenne, E., Higginson, I.J., Hotopf, M., Lloyd-Williams, M., Kaasa, S., Loge, J.H. & European Palliative Care Research Collaborative (EPCRC).(2009). Depression assessment and classification in palliative cancer patients: A systematic literature review.Palliative Medicine, 23, 739–753.
   PubMed Web of Science ®Google Scholar
• Wells, A.A., Palinkas, L.A., Qiu, X. & Ell, K. (2011). Cancer patients’ perspectives on discontinuing depression treatment: The ‘drop out’ phenomenon. Patient Preference and Adherence, 5, 465–470.
   PubMed Web of Science ®Google Scholar
• Wernli, K.J., Hampton, J.M., Trentham-Dietz, A. & Newcomb, P.A. (2009). Antidepressant medication use and breast cancer risk. Pharmacoepidemiology and Drug Safety, 18, 284–290.
   PubMedGoogle Scholar
• Wiffen, P.J., Derry, S. & Moore, R.A. (2011a). Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews, 2, CD006044.
   Google Scholar
• Wiffen, P.J., Derry, S., Moore, R.A. & McQuay, H.J. (2011b). Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews, 1, CD005451.
   PubMedGoogle Scholar
• Wolf, S., Barton, D., Kottschade, L., Grothey, A. & Loprinzi, C. (2008). Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. European Journal of Cancer, 44, 1507–1515.
   PubMed Web of Science ®Google Scholar
• Xu, W., Tamim, H., Shapiro, S., Stang, M.R., Collet, J.P. (2006). Use of antidepressants and risk of colorectal cancer: A nested case-control study. Lancet Oncology, 7, 301–308.
   PubMed Web of Science ®Google Scholar
• Yap, K.Y., Chui, W.K. & Chan, A. (2008). Drug interactions between chemotherapeutic regimens and antiepileptics. Clinical Therapeutics, 30, 1385–1407.
   PubMed Web of Science ®Google Scholar
• Yap, K.Y., Chui, W.K. & Chan, A. (2011a). Onco-Informatics (onco-informatics.com) Group. Development of a chemotherapy regimen interaction database for the mobile Internet: Detecting interactions with psychotropics through OncoRx-MI.Informatics for Health and Social Care, 36, 132–146.
   PubMed Web of Science ®Google Scholar
• Yap, K.Y., Tay, W.L., Chui, W.K. & Chan, A. (2011b). Clinically relevant drug interactions between anticancer drugs and psychotropic agents. European Journal of Cancer Care, 20, 6–32.
   PubMed Web of Science ®Google Scholar
• Zembutsu, H., Sasa, M., Kiyotani, K., Mushiroda, T. & Nakamura, Y. (2011). Should CYP2D6 inhibitors be administered in conjunction with tamoxifen? Expert Review of Anticancer Therapy, 11, 185–193.
   PubMed Web of Science ®Google Scholar